Free Trial

Evercore ISI Cuts DENTSPLY SIRONA (NASDAQ:XRAY) Price Target to $27.00

DENTSPLY SIRONA logo with Medical background

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) had its price objective reduced by analysts at Evercore ISI from $29.00 to $27.00 in a research note issued to investors on Tuesday, Benzinga reports. The brokerage currently has an "outperform" rating on the medical instruments supplier's stock. Evercore ISI's target price suggests a potential upside of 10.29% from the company's current price.

A number of other research analysts also recently issued reports on XRAY. Robert W. Baird lowered their price target on DENTSPLY SIRONA from $33.00 to $31.00 and set a "neutral" rating on the stock in a report on Monday, July 22nd. Needham & Company LLC reaffirmed a "buy" rating and set a $34.00 price target on shares of DENTSPLY SIRONA in a report on Tuesday, August 20th. Barrington Research reiterated an "outperform" rating and issued a $36.00 price target on shares of DENTSPLY SIRONA in a research note on Friday, September 20th. Finally, Stifel Nicolaus lowered their price objective on shares of DENTSPLY SIRONA from $30.00 to $28.00 and set a "hold" rating on the stock in a research report on Thursday, July 18th. Five investment analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $33.22.

Get Our Latest Stock Report on DENTSPLY SIRONA

DENTSPLY SIRONA Stock Performance

DENTSPLY SIRONA stock remained flat at $24.48 during mid-day trading on Tuesday. The company's stock had a trading volume of 1,361,223 shares, compared to its average volume of 3,014,403. DENTSPLY SIRONA has a twelve month low of $23.58 and a twelve month high of $37.60. The company has a quick ratio of 0.87, a current ratio of 1.33 and a debt-to-equity ratio of 0.57. The business has a 50 day simple moving average of $25.38 and a 200 day simple moving average of $27.18. The company has a market capitalization of $5.08 billion, a P/E ratio of -55.64, a PEG ratio of 1.21 and a beta of 1.00.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last announced its quarterly earnings data on Wednesday, July 31st. The medical instruments supplier reported $0.49 EPS for the quarter, missing the consensus estimate of $0.50 by ($0.01). The firm had revenue of $984.00 million for the quarter, compared to analysts' expectations of $993.61 million. DENTSPLY SIRONA had a negative net margin of 4.75% and a positive return on equity of 11.86%. The business's revenue for the quarter was down 4.3% compared to the same quarter last year. During the same period last year, the company posted $0.51 earnings per share. Equities research analysts anticipate that DENTSPLY SIRONA will post 1.99 EPS for the current year.

Institutional Trading of DENTSPLY SIRONA

Hedge funds and other institutional investors have recently bought and sold shares of the stock. GAMMA Investing LLC increased its stake in shares of DENTSPLY SIRONA by 133.4% in the third quarter. GAMMA Investing LLC now owns 2,488 shares of the medical instruments supplier's stock worth $67,000 after purchasing an additional 1,422 shares in the last quarter. Handelsbanken Fonder AB increased its stake in DENTSPLY SIRONA by 61.4% in the 3rd quarter. Handelsbanken Fonder AB now owns 68,100 shares of the medical instruments supplier's stock worth $1,843,000 after buying an additional 25,900 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund bought a new stake in DENTSPLY SIRONA during the second quarter valued at about $1,689,000. Sanctuary Advisors LLC purchased a new position in shares of DENTSPLY SIRONA in the second quarter valued at about $481,000. Finally, Teachers Retirement System of The State of Kentucky boosted its stake in shares of DENTSPLY SIRONA by 264.5% in the second quarter. Teachers Retirement System of The State of Kentucky now owns 70,598 shares of the medical instruments supplier's stock worth $1,758,000 after acquiring an additional 51,228 shares during the period. Hedge funds and other institutional investors own 95.70% of the company's stock.

DENTSPLY SIRONA Company Profile

(Get Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Featured Articles

Analyst Recommendations for DENTSPLY SIRONA (NASDAQ:XRAY)

→ Urgent: This election is rigged (From Porter & Company) (Ad)

Should you invest $1,000 in DENTSPLY SIRONA right now?

Before you consider DENTSPLY SIRONA, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.

While DENTSPLY SIRONA currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Tesla Stock Rockets 15% Post-Earnings

Tesla Stock Rockets 15% Post-Earnings

Will Tesla's rally continue, or is this the time to lock in gains? See how Thomas Hughes suggests playing the market in this exciting post-earnings period.

Related Videos

Tesla Stock: Profits vs. Price—Is It Time to Sell?
Top Stocks to Buy, Sell, and Hold Right Now
Tesla Stock Dip: A Buyer’s Alert

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines